Gastroenterology Practice Questions

Q: A patient with chronic hepatitis B infection develops cirrhosis. What is the most important surveillance measure to implement?

Ultrasound every 6 months. ***Ultrasound every 6 months*** - This is the **most important** surveillance measure for patients with cirrhosis due to chronic hepatitis B, as it effectively screens for **hepatocellular carcinoma (HCC)** [1]. - Early detection of HCC through regular ultrasound significantly improves prognosis by allowing for **curative treatment options** [1]. *Regular liver function tests* - While important for monitoring overall liver health and disease progression, **liver function tests** alone are not sufficient for the early detection of **hepatocellular carcinoma (HCC)** in cirrhotic patients. - They primarily reflect liver synthetic and metabolic function, not the presence of a focal liver lesion. *Annual CT scan* - An **annual CT scan** is not typically recommended as the primary surveillance tool for HCC in cirrhotic patients due to **radiation exposure** and **cost-effectiveness** compared to ultrasound [1]. - CT scans are often used for further characterization of lesions identified on ultrasound or in cases of elevated alpha-fetoprotein [1]. *Biannual endoscopy* - **Biannual endoscopy** is primarily used to screen for and manage **esophageal varices** in cirrhotic patients, which are a common complication of portal hypertension. - While important for evaluating and preventing variceal bleeding, it does not directly screen for the development of **hepatocellular carcinoma (HCC)**.

Q: A 45-year-old male presents with jaundice, pruritus, and fatigue, with a history of ulcerative colitis. Laboratory results show ALP 350, AST 60, ALT 50, and bilirubin 3.5, with AMA negative. MRCP reveals bile duct strictures and dilatation. What is the diagnosis?

Primary sclerosing cholangitis. Detailed Analysis: ***Primary sclerosing cholangitis*** - The combination of **jaundice, pruritus, fatigue**, and **elevated alkaline phosphatase** in a patient with a history of **ulcerative colitis** is highly suggestive of PSC [1]. - **MRCP findings of bile duct strictures and dilatation** are characteristic of PCS, confirming the diagnosis [1]. *Primary biliary cholangitis* - While it presents with similar symptoms (jaundice, pruritus, fatigue) and elevated ALP, **primary biliary cholangitis is typically AMA (anti-mitochondrial antibody) positive** [2]. - PBC mainly affects the **small intrahepatic bile ducts** and does not typically cause the diffuse bile duct strictures and dilatations seen on MRCP in this patient [2]. *Autoimmune hepatitis* - Autoimmune hepatitis is characterized by elevated **aminotransferases (AST/ALT)**, but typically not elevated alkaline phosphatase as the primary finding, and often presents with positive **autoantibodies** such as ANA and ASMA, which are not mentioned [3]. - This condition does not primarily involve bile duct strictures and dilatation. *Choledocholithiasis* - **Choledocholithiasis** (bile duct stones) can cause obstructive jaundice and elevated LFTs, but it typically presents with more acute, fluctuating symptoms and often severe right upper quadrant pain. - While it can cause dilatation, the presence of **multiple strictures and widespread ductal involvement** on MRCP makes PSC a more likely diagnosis than a simple stone.

Q: A patient with a history of chronic pancreatitis presents with a palpable epigastric mass. Which part of the pancreas is most likely involved?

Head. ***Head*** - The **head of the pancreas** is the most common site for **pseudocyst formation** and inflammation in chronic pancreatitis [1]. - An epigastric mass in such a patient often represents a **pancreatic pseudocyst**, which frequently originates in the head due to its anatomical position [1]. *Body* - While the body of the pancreas can be involved in chronic pancreatitis, it is **less commonly associated** with a palpable epigastric mass compared to the head. - Masses in the body are often **deeper** and less likely to be detected on physical examination unless very large. *Tail* - Involvement of the pancreatic tail typically results in symptoms located more to the **left upper quadrant** than the epigastrium. - Pseudocysts or masses in the tail are **infrequent** causes of a central epigastric mass. *Uncinate process* - The uncinate process is a **small, hook-like projection** from the head of the pancreas and is less likely to form a palpable mass on its own. - Pathologies involving the uncinate process are usually considered as part of **head involvement**.

Q: A 70-year-old man with a history of alcohol use presents with worsening confusion and jaundice. Laboratory tests show elevated liver enzymes and hyperbilirubinemia. What management approach is recommended to prevent further deterioration?

Alcohol cessation and supportive care. ***Alcohol cessation and supportive care*** - **Alcohol cessation** is crucial to halt the progression of **alcoholic liver disease**, which is strongly suggested by the patient's history, confusion, jaundice, and elevated liver enzymes [1]. - **Supportive care** involves managing complications such as **hepatic encephalopathy** (confusion), providing adequate nutrition, and addressing any underlying infections [2]. *Nutritional support and monitoring* - While **nutritional support** is an important component of managing alcoholic liver disease, it is not the primary intervention to prevent further deterioration without addressing the root cause. - **Monitoring** alone will not reverse the liver damage caused by continued alcohol consumption. *Liver transplant evaluation* - A **liver transplant** is typically considered for end-stage liver disease after a period of documented **alcohol abstinence** (usually 6 months), which has not yet occurred in this patient. - The immediate priority is to stop the causative agent and stabilize the patient before considering such an invasive procedure. *Iron chelation therapy* - **Iron chelation therapy** is specifically used for conditions involving **iron overload**, such as **hemochromatosis**. - The patient's symptoms and history do not suggest iron overload as the primary cause of his liver disease.

Q: A patient with cirrhosis presents with confusion and asterixis. What is the most likely cause of these symptoms?

Hepatic encephalopathy. ***Hepatic encephalopathy*** - **Cirrhosis** leads to the liver's inability to detoxify harmful substances, specifically **ammonia**, which accumulates and crosses the blood-brain barrier [1]. - This accumulation of neurotoxins causes **neurological impairment**, manifesting as confusion, altered mental status, and the characteristic flapping tremor known as **asterixis** [1]. *Hypoglycemia* - While hypoglycemia can cause confusion, it is less likely to produce **asterixis** and is not directly tied to end-stage liver disease as the primary cause of these specific symptoms [3]. - Diagnosis is confirmed by **low blood glucose levels**, which are not mentioned here as the cause. *Uremia* - **Uremia** results from kidney failure and leads to the accumulation of waste products that can cause **confusion** and altered mental status [2]. - However, asterixis is more prominently associated with hepatic encephalopathy, and the patient's primary diagnosis is **cirrhosis**, not kidney failure [1]. *Diabetic ketoacidosis* - **Diabetic ketoacidosis (DKA)** typically presents with severe hyperglycemia, metabolic acidosis, and can cause confusion and altered mental status. - Asterixis is not a characteristic feature of DKA, and the patient's underlying condition is **cirrhosis**, not uncontrolled diabetes.

Q: A 25-year-old man with a history of Crohn's disease presents with worsening diarrhea and abdominal pain. Which therapeutic strategy would be most appropriate for reducing the progression of his disease?

Anti-TNF monoclonal antibody therapy. A 25-year-old man with a history of Crohn's disease presents with worsening diarrhea and abdominal pain. Which therapeutic strategy would be most appropriate for reducing the progression of his disease? ***Anti-TNF monoclonal antibody therapy*** - **Anti-TNF (tumor necrosis factor) agents** such as infliximab or adalimumab are effective in inducing and maintaining remission in moderate to severe Crohn's disease, thereby reducing disease progression. [1] - They target the **inflammatory cytokine TNF-α**, which plays a central role in the pathogenesis of inflammatory bowel disease (IBD). *Long-term antibiotics* - While antibiotics may be used for specific complications like **perianal disease** or **bacterial overgrowth** in Crohn's, they are not a primary strategy for long-term reduction of disease progression in general. - **Chronic antibiotic use** can lead to side effects such as *Clostridioides difficile* infection and **antibiotic resistance**. *Corticosteroid therapy for 6 months* - **Corticosteroids** are effective for inducing remission in acute flares of Crohn's disease due to their potent anti-inflammatory effects. [1] - However, they are not suitable for **long-term maintenance therapy** due to significant side effects (e.g., bone loss, adrenal suppression, increased infection risk) and do not alter the natural course of the disease. [1] *High-fiber diet and exercise* - A **high-fiber diet** is generally not recommended during active flares of Crohn's disease as it can worsen symptoms like abdominal pain and diarrhea. - While **exercise** is beneficial for overall health, neither dietary changes nor exercise alone are sufficient to reduce the progression of moderate to severe Crohn's disease.

Q: Which condition is commonly associated with Helicobacter pylori infection?

Gastric ulcers. ***Gastric ulcers*** - **Helicobacter pylori** infection is a primary cause of **gastric ulcers** due to its ability to damage the protective mucosal lining of the stomach [1]. - The bacteria produce **urease**, which neutralizes stomach acid locally, allowing it to colonize and trigger inflammation [1]. *Appendicitis* - **Appendicitis** is typically caused by obstruction of the appendix lumen, often by a **fecalith** or lymphoid hyperplasia, leading to inflammation and infection. - While bacteria are involved in the infection that follows obstruction, **H. pylori** is not a known causative agent for appendicitis. *Pancreatitis* - **Pancreatitis** is an inflammation of the pancreas, most commonly caused by **gallstones** or **alcohol abuse**. - **H. pylori** infection is not implicated in the pathogenesis of pancreatitis. *Hepatitis* - **Hepatitis** refers to inflammation of the liver, predominantly caused by **viruses** (e.g., Hepatitis A, B, C), **alcohol**, or certain **drugs**. - **H. pylori** does not cause hepatitis; its primary site of infection is the gastric mucosa [2].

Q: What is the gold standard diagnostic test for a suspected peptic ulcer?

Upper gastrointestinal endoscopy. ***Upper gastrointestinal endoscopy*** - This is the **gold standard** because it allows for direct visualization of the esophagus, stomach, and duodenum, enabling accurate identification and **biopsy** of ulcers [1]. - Endoscopy can also be therapeutic, allowing for interventions like **hemostasis** if bleeding is present [1]. *Barium swallow* - A barium swallow is a **radiologic study** that can identify ulcers as filling defects or craters, but it is less sensitive and specific than endoscopy. - It does not allow for **biopsy** to rule out malignancy or confirm *Helicobacter pylori* infection. *Abdominal ultrasound* - An abdominal ultrasound is primarily used to evaluate **solid organs** like the liver, gallbladder, and kidneys [2]. - It has very limited utility in visualizing the gastric or duodenal mucosa and therefore cannot reliably detect **peptic ulcers**. *CT scan of the abdomen* - A CT scan can detect complications of peptic ulcers such as **perforation** or **obstruction**, but it is not the primary diagnostic tool for identifying the ulcer itself. - It does not offer the same **mucosal detail** or biopsy capability as endoscopy.

Q: A 30-year-old patient with a history of Crohn's disease presents with acute abdominal pain. A CT scan reveals bowel wall thickening and fat stranding. What is the most likely diagnosis?

Active Crohn's disease. ***Active Crohn's disease*** - The patient's history of **Crohn's disease**, combined with **acute abdominal pain**, and CT findings of **bowel wall thickening** and **fat stranding**, are highly suggestive of an active flare-up [1]. - **Fat stranding** results from inflammation spreading into adjacent mesenteric fat, a common finding in active inflammatory bowel disease. *Intestinal obstruction* - While **bowel wall thickening** can be present in obstruction, the primary CT finding would be **dilated bowel loops** proximal to a transition point, often with air-fluid levels [1]. - Although Crohn's can cause strictures leading to obstruction, the description points more directly to active inflammation. *Diverticulitis* - **Diverticulitis** typically occurs in older individuals and is characterized by inflammation of colonic diverticula, presenting with **left lower quadrant pain** and localized inflammation or abscess. - While it can cause **bowel wall thickening** and **fat stranding**, the patient's history of **Crohn's disease** makes an active flare-up far more likely [1]. *Colonic carcinoma* - **Colonic carcinoma** can cause **bowel wall thickening**, but it often presents as a focal **mass** or **asymmetric thickening** with associated lymphadenopathy, and a more insidious onset of symptoms [1]. - Although patients with Crohn's have an increased risk of colorectal cancer, the acute presentation and diffuse inflammatory signs (fat stranding) point away from primary carcinoma as the most likely immediate cause.

Question 1

A patient with chronic hepatitis B infection develops cirrhosis. What is the most important surveillance measure to implement?

Accepted Answer

Ultrasound every 6 months

Answer

Regular liver function tests

Answer

Annual CT scan

Answer

Biannual endoscopy

Question 2

A 45-year-old male presents with jaundice, pruritus, and fatigue, with a history of ulcerative colitis. Laboratory results show ALP 350, AST 60, ALT 50, and bilirubin 3.5, with AMA negative. MRCP reveals bile duct strictures and dilatation. What is the diagnosis?

Accepted Answer

Primary sclerosing cholangitis

Answer

Autoimmune hepatitis

Answer

Choledocholithiasis

Answer

Primary biliary cholangitis

Question 3

A patient with a history of chronic pancreatitis presents with a palpable epigastric mass. Which part of the pancreas is most likely involved?

Accepted Answer

Head

Answer

Body

Answer

Tail

Answer

Uncinate process

Question 4

A 70-year-old man with a history of alcohol use presents with worsening confusion and jaundice. Laboratory tests show elevated liver enzymes and hyperbilirubinemia. What management approach is recommended to prevent further deterioration?

Accepted Answer

Alcohol cessation and supportive care

Answer

Nutritional support and monitoring

Answer

Liver transplant evaluation

Answer

Iron chelation therapy

Question 5

A patient with cirrhosis presents with confusion and asterixis. What is the most likely cause of these symptoms?

Accepted Answer

Hepatic encephalopathy

Answer

Hypoglycemia

Answer

Uremia

Answer

Diabetic ketoacidosis

Question 6

A 25-year-old man with a history of Crohn's disease presents with worsening diarrhea and abdominal pain. Which therapeutic strategy would be most appropriate for reducing the progression of his disease?

Accepted Answer

Anti-TNF monoclonal antibody therapy

Answer

Long-term antibiotics

Answer

Corticosteroid therapy for 6 months

Answer

High-fiber diet and exercise

Question 7

Which condition is commonly associated with Helicobacter pylori infection?

Accepted Answer

Gastric ulcers

Answer

Appendicitis

Answer

Pancreatitis

Answer

Hepatitis

Question 8

A 55-year-old male with a history of alcohol abuse presents with necrotizing pancreatitis. What are the key factors to consider in the management of this condition?

Accepted Answer

Extent of necrosis, presence of infection, and patient’s overall clinical status are key factors.

Answer

Patient’s age and personal preference are important.

Answer

Availability of surgical equipment may influence the decision.

Answer

Cost of procedure is a consideration.

Question 9

What is the gold standard diagnostic test for a suspected peptic ulcer?

Accepted Answer

Upper gastrointestinal endoscopy

Answer

Barium swallow

Answer

Abdominal ultrasound

Answer

CT scan of the abdomen

Question 10

A 30-year-old patient with a history of Crohn's disease presents with acute abdominal pain. A CT scan reveals bowel wall thickening and fat stranding. What is the most likely diagnosis?

Accepted Answer

Active Crohn's disease

Answer

Intestinal obstruction

Answer

Diverticulitis

Answer

Colonic carcinoma

Gastroenterology — MCQs

Gastroenterology — MCQs

On this page

Practice by Chapter

Want unlimited practice?